Proteomics and Population Biology in the Cardiovascular Health Study (CHS): design of a study with mentored access and active data sharing

[1]  R. Vasan,et al.  Circulating testican-2 is a podocyte-derived marker of kidney health , 2020, Proceedings of the National Academy of Sciences.

[2]  P. Visscher,et al.  A resource-efficient tool for mixed model association analysis of large-scale data , 2019, Nature Genetics.

[3]  Brian E. Cade,et al.  Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program , 2019, Nature.

[4]  Mary E. Haas,et al.  Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations , 2018, Nature Genetics.

[5]  Stephen Burgess,et al.  Genomic atlas of the human plasma proteome , 2018, Nature.

[6]  R. Vasan,et al.  Genetic Architecture of the Cardiovascular Risk Proteome , 2017, Circulation.

[7]  P. Libby,et al.  Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease , 2017, The New England journal of medicine.

[8]  G. Aurigemma,et al.  Activation of Inflammatory and Pro-Thrombotic Pathways in Acute Stress Cardiomyopathy , 2017, Front. Cardiovasc. Med..

[9]  Richard G. Lee,et al.  Cardiovascular and Metabolic Effects of ANGPTL3 Antisense Oligonucleotides , 2017, The New England journal of medicine.

[10]  Robert E. Gerszten,et al.  Emerging Affinity-Based Proteomic Technologies for Large-Scale Plasma Profiling in Cardiovascular Disease , 2017, Circulation.

[11]  B. Psaty,et al.  Soluble ST2 for Prediction of Heart Failure and Cardiovascular Death in an Elderly, Community‐Dwelling Population , 2016, Journal of the American Heart Association.

[12]  Xu Shi,et al.  Aptamer-Based Proteomic Profiling Reveals Novel Candidate Biomarkers and Pathways in Cardiovascular Disease , 2016, Circulation.

[13]  Brian R. Kotajarvi,et al.  Quantification of GDF11 and Myostatin in Human Aging and Cardiovascular Disease. , 2016, Cell metabolism.

[14]  James T. Elder,et al.  Investigating the Causal Relationship of C-Reactive Protein with 32 Complex Somatic and Psychiatric Outcomes: A Large-Scale Cross-Consortium Mendelian Randomization Study , 2016, PLoS medicine.

[15]  L. Kuller,et al.  Study of Cardiovascular Health Outcomes in the Era of Claims Data: The Cardiovascular Health Study , 2016, Circulation.

[16]  David A. Knowles,et al.  An Efficient Multiple-Testing Adjustment for eQTL Studies that Accounts for Linkage Disequilibrium between Variants. , 2016, American journal of human genetics.

[17]  S. Carr,et al.  Multiplexed Immunoaffinity Enrichment of Peptides with Anti-peptide Antibodies and Quantification by Stable Isotope Dilution Multiple Reaction Monitoring Mass Spectrometry. , 2016, Methods in molecular biology.

[18]  C. Sander,et al.  Applications of targeted proteomics in systems biology and translational medicine , 2015, Proteomics.

[19]  K. Lunetta,et al.  Integrating Genetic, Transcriptional, and Functional Analyses to Identify 5 Novel Genes for Atrial Fibrillation , 2014, Circulation.

[20]  E. Rimm,et al.  Fibrosis-Related Biomarkers and Incident Cardiovascular Disease in Older Adults: The Cardiovascular Health Study , 2014, Circulation. Arrhythmia and electrophysiology.

[21]  Kathleen F. Kerr,et al.  Net reclassification indices for evaluating risk prediction instruments: a critical review. , 2014, Epidemiology.

[22]  Paolo Vineis,et al.  Deciphering the complex: Methodological overview of statistical models to derive OMICS‐based biomarkers , 2013, Environmental and molecular mutagenesis.

[23]  Richard T. Lee,et al.  Growth Differentiation Factor 11 Is a Circulating Factor that Reverses Age-Related Cardiac Hypertrophy , 2013, Cell.

[24]  Rachel Ostroff,et al.  Highly multiplexed proteomic platform for biomarker discovery, diagnostics, and therapeutics. , 2013, Advances in experimental medicine and biology.

[25]  R. Fabsitz,et al.  Social network analysis comparing researcher collaborations in two cardiovascular cohort studies , 2012 .

[26]  Stephen Burgess,et al.  Improving bias and coverage in instrumental variable analysis with weak instruments for continuous and binary outcomes , 2012, Statistics in medicine.

[27]  Jennifer G. Robinson,et al.  The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis , 2012, The Lancet.

[28]  C. Mantzoros,et al.  Total and High-Molecular-Weight Adiponectin and Risk of Incident Diabetes in Older People , 2012, Diabetes Care.

[29]  D R Mani,et al.  Interlaboratory Evaluation of Automated, Multiplexed Peptide Immunoaffinity Enrichment Coupled to Multiple Reaction Monitoring Mass Spectrometry for Quantifying Proteins in Plasma* , 2011, Molecular & Cellular Proteomics.

[30]  Ali Shojaie,et al.  Penalized Principal Component Regression on Graphs for Analysis of Subnetworks , 2010, NIPS.

[31]  Tracy R. Keeney,et al.  Aptamer-based multiplexed proteomic technology for biomarker discovery , 2010, Nature Precedings.

[32]  G. Michailidis,et al.  Network Enrichment Analysis in Complex Experiments , 2010, Statistical applications in genetics and molecular biology.

[33]  Hao Helen Zhang,et al.  ON THE ADAPTIVE ELASTIC-NET WITH A DIVERGING NUMBER OF PARAMETERS. , 2009, Annals of statistics.

[34]  Ali Shojaie,et al.  Analysis of Gene Sets Based on the Underlying Regulatory Network , 2009, J. Comput. Biol..

[35]  K. Lunetta,et al.  Methods in Genetics and Clinical Interpretation Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium Design of Prospective Meta-Analyses of Genome-Wide Association Studies From 5 Cohorts , 2010 .

[36]  Holly Janes,et al.  Assessing the Value of Risk Predictions by Using Risk Stratification Tables , 2008, Annals of Internal Medicine.

[37]  George Davey Smith,et al.  Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology , 2008, Statistics in medicine.

[38]  Geoffrey E. Hinton,et al.  Visualizing Data using t-SNE , 2008 .

[39]  A. Reiner,et al.  Inflammation and hemostasis biomarkers and cardiovascular risk in the elderly: the Cardiovascular Health Study , 2007, Journal of thrombosis and haemostasis : JTH.

[40]  Eric Boerwinkle,et al.  Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL , 2007, Nature Genetics.

[41]  Charles E. Heckler,et al.  Applied Multivariate Statistical Analysis , 2005, Technometrics.

[42]  Darryl B. Hardie,et al.  Mass spectrometric quantitation of peptides and proteins using Stable Isotope Standards and Capture by Anti-Peptide Antibodies (SISCAPA). , 2004, Journal of proteome research.

[43]  S. Ebrahim,et al.  'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? , 2003, International journal of epidemiology.

[44]  C. Furberg,et al.  Frequency and predictors of stroke death in 5,888 participants in the Cardiovascular Health Study , 2001, Neurology.

[45]  J. Gardin,et al.  Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study. , 2000, Journal of the American College of Cardiology.

[46]  L H Kuller,et al.  Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[47]  R. Tibshirani.  Regression Shrinkage and Selection via the Lasso , 1996 .

[48]  L H Kuller,et al.  Surveillance and ascertainment of cardiovascular events. The Cardiovascular Health Study. , 1995, Annals of epidemiology.

[49]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[50]  J. Gardin,et al.  Assessment of cerebrovascular disease in the Cardiovascular Health Study. , 1993, Annals of epidemiology.

[51]  L. Fried,et al.  Recruitment of adults 65 years and older as participants in the Cardiovascular Health Study. , 1993, Annals of epidemiology.

[52]  R. Kronmal,et al.  The Cardiovascular Health Study: design and rationale. , 1991, Annals of epidemiology.